Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells
about
Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growthIL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesisTherapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammationExpression of silencer of death domains and death-receptor-3 in normal human kidney and in rejecting renal transplantsCytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBDRoles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular DiseaseOsteoprotegerin rich tumor microenvironment: implications in breast cancerMembrane trafficking of death receptors: implications on signallingApoptosis: role in myeloid cell developmentOsteoprotegerin in breast cancer: beyond bone remodelingIdentification of a receptor for BLyS demonstrates a crucial role in humoral immunityTL1A-induced NF-kappaB activation and c-IAP2 production prevent DR3-mediated apoptosis in TF-1 cellsOn death receptor 3 and its ligands…Vascular endothelial growth inhibitor (VEGI), an endogenous negative regulator of angiogenesisRole of TL1A and its receptor DR3 in two models of chronic murine ileitis.The role of tumor necrosis factor receptor superfamily members in mammalian brain development, function and homeostasisDR3 regulates negative selection during thymocyte developmentVEGI, a new member of the TNF family activates nuclear factor-kappa B and c-Jun N-terminal kinase and modulates cell growth.Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interactionThe role of cytokines in skeletal remodelling: possible consequences for renal osteodystrophy.Receptor activator of nuclear factor-kappaB ligand and osteoprotegerin: potential implications for the pathogenesis and treatment of malignant bone diseases.Two functionally distinct isoforms of TL1A (TNFSF15) generated by differential ectodomain sheddingHerpes simplex virus glycoprotein D interferes with binding of herpesvirus entry mediator to its ligands through downregulation and direct competitionTL1, a novel tumor necrosis factor-like cytokine, induces apoptosis in endothelial cells. Involvement of activation of stress protein kinases (stress-activated protein kinase and p38 mitogen-activated protein kinase) and caspase-3-like protease.Isoform of vascular endothelial cell growth inhibitor (VEGI72-251) increases interleukin-2 production by activation of T lymphocytes.Meta-analysis of genome-wide association studies identifies two loci associated with circulating osteoprotegerin levelsThe TNF-family cytokine TL1A inhibits proliferation of human activated B cellsSemen Astragali Complanati- and Rhizoma Cibotii-enhanced bone formation in osteoporosis rats.The adaptor protein TRADD is essential for TNF-like ligand 1A/death receptor 3 signaling.Plasma and drainage fluid levels of soluble receptor activator of nuclear factor-kB (sRANK), soluble receptor activator of nuclear factor-kB ligand (sRANKL) and osteoprotegerin (OPG) during proximal humerus fracture healing.Monocytes treated with human immunodeficiency virus Tat kill uninfected CD4(+) cells by a tumor necrosis factor-related apoptosis-induced ligand-mediated mechanism.Structure-based mutagenesis of herpes simplex virus glycoprotein D defines three critical regions at the gD-HveA/HVEM binding interface.Progranulin-derived Atsttrin directly binds to TNFRSF25 (DR3) and inhibits TNF-like ligand 1A (TL1A) activity.Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort.TNFSF15 Modulates Neovascularization and InflammationOsteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis.Increased expression of TNF ligand-related molecule 1A and death receptor 3 in bladder tissues of patients with painful bladder syndrome/interstitial cystitis.Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia.Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation.The role of TRADD in death receptor signaling
P2860
Q22003914-C56E1C6B-5C7D-4FBD-B5FC-D5C6C62ED5A6Q24563235-F55409BD-26AE-48D0-94CD-FF7A1620E7A3Q24598725-578AB3C3-40A3-4327-B1D7-62A03C46841FQ24685457-0BFDF62D-44AA-40AE-8D19-03D0185D131FQ26740540-A68C6AD6-4472-4674-9C19-AC18FC5D5C30Q26747224-9E9566FD-1130-4EC2-A339-406293235022Q26748804-02E1A993-3C4C-4E60-ACB2-53EABA2B8F5FQ26852802-712C2C96-C7F4-4614-B7BE-AD893C4AB6C9Q27016041-80E33CC5-D486-4C39-AEF5-08FE21D87682Q28081803-C08EC53D-FAEE-4A50-8E6A-C39A0EC3169FQ28139967-9629E3AD-993F-44DB-8A05-B231B8C90711Q28189886-39A7E75D-CEE8-43DF-973C-429EDCD4DA94Q28267084-8865FD1B-24EF-4A87-90BB-BE21BB8B1FE8Q28300434-73138EE7-E9D8-4CF7-A67E-14C51696E640Q30440458-906A0944-1934-44AA-A05A-A0C6093A9494Q30463364-12264EE5-B67D-4BBE-8059-926AC4230578Q33558790-8BFCDBA0-9BBE-4549-BE23-F93C492C1B53Q33883558-588F657F-FB3A-4162-BDCD-88E73973BE7DQ33886695-AB48FD26-A2FB-494A-8561-9CEA6C56E8A3Q33947732-A1F37417-3767-4056-9D21-AC3002335624Q34086847-1092A01B-0E38-406A-8AE8-611EBFA804D9Q34195262-82BF49B9-F30E-4CBF-9C6F-E3CC99F60BB4Q34295959-D548237E-4CC3-4FE2-B6D6-94BFEA239D43Q34486473-BA78BB41-EACF-453E-A648-BC87ABAF56D6Q34512228-A7D5F980-498A-448E-AC70-B919BB16EFE1Q34555532-BB22C6A4-EBA1-4C98-A1FB-91131926E32DQ34658152-9B2F2B52-2416-4C0B-89F1-B79579D49255Q34778152-5294CA87-417D-451D-AF38-ABCC32866BD1Q34827734-84CDB9FF-019A-41E0-9306-8E711F40CBE1Q34828137-1360E86C-41FD-45DF-94F3-931CDA5AA39BQ35020357-20F61042-19EE-4424-8544-12788D53E2BEQ35105049-3D44D0AE-23CE-41DB-9E31-CB7E25163491Q35126225-A72E2D5F-DAC4-451B-80A1-E601B24BE839Q36273402-B8B89542-199A-45D5-96BB-3971EE2F6067Q36284920-48E8CEBF-D726-4312-B5A8-69ABEDCDC1D2Q36368706-397E7823-571C-4025-B1F5-8903B3FBC3DCQ36471651-C868EE69-A985-4F2C-855A-595E7360902FQ36544769-C2917ADC-5F01-487C-A5B1-4D878A222672Q36639967-F88D78E5-41A4-4FCC-BE49-F9B4365E7CEDQ36920268-8D044319-B825-4262-B94C-8621DDBCCF82
P2860
Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells
description
1997 nî lūn-bûn
@nan
1997 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Characterization of a novel TN ...... ic and non-hematopoietic cells
@ast
Characterization of a novel TN ...... ic and non-hematopoietic cells
@en
Characterization of a novel TN ...... ic and non-hematopoietic cells
@en-gb
Characterization of a novel TN ...... ic and non-hematopoietic cells
@nl
type
label
Characterization of a novel TN ...... ic and non-hematopoietic cells
@ast
Characterization of a novel TN ...... ic and non-hematopoietic cells
@en
Characterization of a novel TN ...... ic and non-hematopoietic cells
@en-gb
Characterization of a novel TN ...... ic and non-hematopoietic cells
@nl
prefLabel
Characterization of a novel TN ...... ic and non-hematopoietic cells
@ast
Characterization of a novel TN ...... ic and non-hematopoietic cells
@en
Characterization of a novel TN ...... ic and non-hematopoietic cells
@en-gb
Characterization of a novel TN ...... ic and non-hematopoietic cells
@nl
P2093
P921
P3181
P1433
P1476
Characterization of a novel TN ...... ic and non-hematopoietic cells
@en
P2093
P3181
P356
10.1016/S0378-1119(97)00509-X
P407
P577
1997-12-19T00:00:00Z